Managed Healthcare Executive1d
FDA Approves Spravato Nasal Spray as a Standalone Treatment for Major Depressive Disorder
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
Hosted on MSN1d
FDA approves first nasal spray treatment for severe depression
The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe depression. It is now the first-ever stand-alone therapy for treatment-resistant ...
The Pharma Letter2d
J&J’s Spravato first approval as monotherapy for treatment-resistant depression
US healthcare giant Johnson & Johnson announced the US Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Spravato (esketamine) CIII nasal spray as the first ...
Inquirer on MSN3d
Controlled drug Ketamine a lifeline for patients with severe depression in S’pore
Ketamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.
Medindia3d
SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression
Kelsey Warren [email protected]  609 218 4053 Investor contact: Lauren Johnson [email protected] ...
Philippine Daily Inquirer3d
Ketamine a lifeline for severe depression patients in Singapore
Since October 2020 – when the Health Sciences Authority (HSA) first authorized sale of an esketamine nasal ... the cost of oral anti-depressants, which must accompany any Spravato course ...
The Star3d
Controlled drug Ketamine a lifeline for patients with severe depression in Singapore
Once seen as an alternative option, the ketamine nasal spray Spravato is ... The bill does not include the cost of oral anti-depressants, which must accompany any Spravato course, and the talk ...
Controlling infections might reduce risk of dementia, study says
Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal ...